Fluticasone propionate; Salmeterol xinafoate - search results

Ireland - English - HPRA (Health Products Regulatory Authority)

sirdupla 25 microgram/125 microgram per metered dose pressurised inhalation, suspension

mcdermott laboratories ltd., t/a gerard laboratories - salmeterol xinafoate; fluticasone propionate - pressurised inhalation, suspension - 25mcg /125 microgram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Ireland - English - HPRA (Health Products Regulatory Authority)

sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension

mcdermott laboratories ltd., t/a gerard laboratories - salmeterol xinafoate; fluticasone propionate - pressurised inhalation, suspension - 25mcg/250 microgram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Ireland - English - HPRA (Health Products Regulatory Authority)

airflusal forspiro 50 microgram/500 microgram/dose, inhalation powder, predispensed

lexon pharmaceuticals (ireland) limited - salmeterol xinafoate; fluticasone propionate - inhalation powder, pre-dispensed - 50/500 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Ireland - English - HPRA (Health Products Regulatory Authority)

sirdupla 25 microgram/125 microgram per metered dose pressurised inhalation, suspension

viatris limited - salmeterol xinafoate; fluticasone propionate - pressurised inhalation, suspension - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Ireland - English - HPRA (Health Products Regulatory Authority)

sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension

Australia - English - Department of Health (Therapeutic Goods Administration)

seroflo multihaler 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed bp plastic inhaler

cipla australia pty ltd - salmeterol xinafoate, quantity: 0.0725 mg; fluticasone propionate, quantity: 0.25 mg - inhalation, powder for - excipient ingredients: lactose monohydrate - for the regular treatment of asthma, where the use of a combination product is appropriate. this may include,? patients on effective maintenance doses of long acting beta 2 agonists and inhaled corticosteroids ? patients who are symptomatic on current inhaled corticosteroid therapy for the symptomatic treatment of patients with severe copd (fev1 not more than 50 per cent predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular beta 2 agonist bronchodilator therapy. seroflo multihaler 250/50 is not indicated for the initiation of bronchodilator therapy in copd.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

seretide accuhaler / diskus 50mcg+100mcg powder for inhalation

glaxo wellcome production - salmeterol (salmeterol xinafoate), fluticasone (fluticasone propionate) - powder for inhalation - 50mcg+100mcg

seretide accuhaler / diskus 50mcg+500mcg powder for inhalation

glaxo wellcome production - salmeterol (salmeterol xinafoate), fluticasone (fluticasone propionate) - powder for inhalation - 50mcg+500mcg

seretide accuhaler / diskus 50mcg+250mcg powder for inhalation

glaxo wellcome production - salmeterol (salmeterol xinafoate), fluticasone (fluticasone propionate) - powder for inhalation - 50mcg+250mcg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

seretide 250 evohaler

de pharmaceuticals - fluticasone propionate; salmeterol xinafoate - pressurised inhalation - 250microgram/1dose ; 25microgram/1dose